首页> 外文期刊>Advances in pharmacy >C-Reactive Protein and Cardiovascular Risk Assessment
【24h】

C-Reactive Protein and Cardiovascular Risk Assessment

机译:C反应蛋白与心血管风险评估

获取原文
获取原文并翻译 | 示例
           

摘要

Traditional strategies for lowering cardiovascular disease (CVD) risk focuses on the modification and control of well-established risk factors. Despite detection, prevention, modification, and treatment of these risk factors, cardiovascular disease remains the leading cause of death in the US. While research continues to assess the complex link between traditional risk factors and CVD, novel cardiovascular risks are being evaluated for possible contributory roles in the pathogenesis and progression of CVD. C-reactive protein (CRP) is one such risk factor that is gaining widespread attention. Current evidence points to a positive link between elevated CRP and CVD. Additional work in this area is needed to fully understand the absolute risk correlation between elevated CRP and resultant CVD.
机译:降低心血管疾病(CVD)风险的传统策略着重于改进和控制已建立的风险因素。尽管对这些危险因素进行了检测,预防,修饰和治疗,但是心血管疾病仍然是美国的主要死亡原因。尽管研究继续评估传统危险因素与CVD之间的复杂联系,但正在评估新型心血管风险,以探讨其在CVD的发病机理和进展中的可能作用。 C反应蛋白(CRP)是引起广泛关注的此类危险因素之一。目前的证据表明,升高的CRP和CVD之间存在正向联系。为了充分了解升高的CRP与产生的CVD之间的绝对风险相关性,还需要在这一领域进行其他工作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号